Markus Lakemeyer

575 total citations
16 papers, 447 citations indexed

About

Markus Lakemeyer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Markus Lakemeyer has authored 16 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Markus Lakemeyer's work include Biochemical and Structural Characterization (6 papers), Peptidase Inhibition and Analysis (6 papers) and Click Chemistry and Applications (4 papers). Markus Lakemeyer is often cited by papers focused on Biochemical and Structural Characterization (6 papers), Peptidase Inhibition and Analysis (6 papers) and Click Chemistry and Applications (4 papers). Markus Lakemeyer collaborates with scholars based in Germany, United States and Canada. Markus Lakemeyer's co-authors include Stephan A. Sieber, Peter Hammann, Weining Zhao, Matthew Bogyo, Mathias W. Hackl, Brett M. Babin, Axel Pahl, Herbert Waldmann, Vadim S. Korotkov and Thomas Böttcher and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Chemical Communications.

In The Last Decade

Markus Lakemeyer

15 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Lakemeyer Germany 10 255 104 66 65 60 16 447
Do-Yeon Kwon United States 9 301 1.2× 92 0.9× 44 0.7× 46 0.7× 63 1.1× 17 474
Charlotte K. Hind United Kingdom 17 332 1.3× 224 2.2× 40 0.6× 63 1.0× 35 0.6× 50 655
Tao Cui United States 11 424 1.7× 69 0.7× 49 0.7× 35 0.5× 22 0.4× 19 639
Sankaralingam Saikolappan United States 13 288 1.1× 31 0.3× 47 0.7× 101 1.6× 53 0.9× 14 598
Walid A. M. Elgaher Germany 13 207 0.8× 121 1.2× 25 0.4× 36 0.6× 37 0.6× 30 428
Cammy K.-M. Chen Taiwan 8 473 1.9× 96 0.9× 125 1.9× 55 0.8× 26 0.4× 9 640
J. Jacob Strouse United States 11 215 0.8× 67 0.6× 85 1.3× 118 1.8× 28 0.5× 15 505
Mark Mabanglo Canada 13 399 1.6× 49 0.5× 81 1.2× 57 0.9× 14 0.2× 19 558
Marc A. Boudreau United States 11 234 0.9× 165 1.6× 17 0.3× 69 1.1× 27 0.5× 12 476

Countries citing papers authored by Markus Lakemeyer

Since Specialization
Citations

This map shows the geographic impact of Markus Lakemeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Lakemeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Lakemeyer more than expected).

Fields of papers citing papers by Markus Lakemeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Lakemeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Lakemeyer. The network helps show where Markus Lakemeyer may publish in the future.

Co-authorship network of co-authors of Markus Lakemeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Lakemeyer. A scholar is included among the top collaborators of Markus Lakemeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Lakemeyer. Markus Lakemeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lakemeyer, Markus, Rocco Latorre, Hannah M. Wood, et al.. (2025). A Bacteroides fragilis protease activates host PAR2 to induce intestinal pain and inflammation. Cell Host & Microbe. 33(10). 1686–1702.e11.
2.
Lakemeyer, Markus, Andreas Kulik, Nicole Staudt, et al.. (2023). Structure of Staphylococcus aureus ClpP Bound to the Covalent Active‐Site Inhibitor Cystargolide A. Angewandte Chemie. 136(3). 1 indexed citations
3.
Lakemeyer, Markus, Andreas Kulik, Nicole Staudt, et al.. (2023). Structure of Staphylococcus aureus ClpP Bound to the Covalent Active‐Site Inhibitor Cystargolide A. Angewandte Chemie International Edition. 63(3). e202314028–e202314028. 8 indexed citations
4.
Nguyen, Taylor H., Markus Lakemeyer, Rachael B. Chanin, et al.. (2023). Chemoproteomic identification of a DPP4 homolog in Bacteroides thetaiotaomicron. Nature Chemical Biology. 19(12). 1469–1479. 10 indexed citations
5.
Thomy, Dhana, Markus Lakemeyer, Joaquı́n Ortega, et al.. (2022). Antibiotic Acyldepsipeptides Stimulate the Streptomyces Clp-ATPase/ClpP Complex for Accelerated Proteolysis. mBio. 13(6). e0141322–e0141322. 7 indexed citations
6.
Lakemeyer, Markus, et al.. (2022). Integration of bioinformatic and chemoproteomic tools for the study of enzyme conservation in closely related bacterial species. Methods in enzymology on CD-ROM/Methods in enzymology. 664. 1–22. 3 indexed citations
7.
Onguka, Ouma, Brett M. Babin, Markus Lakemeyer, et al.. (2021). Toxoplasma gondii serine hydrolases regulate parasite lipid mobilization during growth and replication within the host. Cell chemical biology. 28(10). 1501–1513.e5. 6 indexed citations
8.
Lakemeyer, Markus, Eva Bertosin, Friederike M. Möller, et al.. (2019). Tailored Peptide Phenyl Esters Block ClpXP Proteolysis by an Unusual Breakdown into a Heptamer–Hexamer Assembly. Angewandte Chemie International Edition. 58(21). 7127–7132. 12 indexed citations
9.
Babin, Brett M., et al.. (2019). Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communities. Current Opinion in Chemical Biology. 54. 45–53. 53 indexed citations
10.
Lakemeyer, Markus, et al.. (2018). Thinking Outside the Box—Novel Antibacterials To Tackle the Resistance Crisis. Angewandte Chemie International Edition. 57(44). 14440–14475. 138 indexed citations
11.
Lakemeyer, Markus, et al.. (2018). Über bisherige Denkweisen hinaus – neue Wirkstoffe zur Überwindung der Antibiotika‐Krise. Angewandte Chemie. 130(44). 14642–14682. 17 indexed citations
12.
Lakemeyer, Markus, et al.. (2018). Design and synthesis of tailored human caseinolytic protease P inhibitors. Chemical Communications. 54(70). 9833–9836. 28 indexed citations
13.
Krysiak, Joanna, et al.. (2017). Quantitative Map of β-Lactone-Induced Virulence Regulation. Journal of Proteome Research. 16(3). 1180–1192. 20 indexed citations
14.
Pahl, Axel, Markus Lakemeyer, Mathias W. Hackl, et al.. (2015). Reversible Inhibitors Arrest ClpP in a Defined Conformational State that Can Be Revoked by ClpX Association. Angewandte Chemie International Edition. 54(52). 15892–15896. 40 indexed citations
15.
Pahl, Axel, Markus Lakemeyer, Mathias W. Hackl, et al.. (2015). Reversible Inhibitoren arretieren ClpP in einer definierten Konformation, die durch Bindung von ClpX aufgehoben wird. Angewandte Chemie. 127(52). 16121–16126. 15 indexed citations
16.
Hackl, Mathias W., Markus Lakemeyer, Axel Pahl, et al.. (2015). Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization. Journal of the American Chemical Society. 137(26). 8475–8483. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026